PCAST Members Ready To Speak; President Seems Ready To Listen

Bush has attended each of the White House panel's meetings, raising hopes that PCAST will have an impact on science policy WASHINGTON -- On the job for barely three months, the members of the President's Council of Advisers on Science and Technology are pleased that President Bush has attended at least a portion of each of their meetings. Powerful figures in their own right, they know that direct access to the Oval Office is one important measure of political clout in this city. But the 12 me

Written byJeffrey Mervis
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share


Bush has attended each of the White House panel's meetings, raising hopes that PCAST will have an impact on science policy
WASHINGTON -- On the job for barely three months, the members of the President's Council of Advisers on Science and Technology are pleased that President Bush has attended at least a portion of each of their meetings. Powerful figures in their own right, they know that direct access to the Oval Office is one important measure of political clout in this city.

But the 12 members of PCAST say that access is not enough. It's the message that matters, they say. And they add that the jury's still out on whether they will actually make a difference in shaping U.S. science and technology policy in the 1990s.

"I don't think that we'll have any problem being heard," says Harold Shapiro, president of Princeton University. "The challenge is to have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies